GENPHARM SERVICES

"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"

ABOUT US

Genpharm Services is a financially sound privately owned company based in the Dubai Science Park (DSP), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.

Genpharm's Corporate Video

"See Genpharm’s Corporate Video presentation. Hear from the founders and employees about the mission of Genpharm. Listen to how employees are contributing to the community and empowering the Rare Disease Community in the MENA region.

Pharmaceutical Strategic Advice

"We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio. "

Featured in Life Science Leader Magazine: The MENA Pharma Market an Untapped Opportunity

" By Genpharm’s CEO Karim Smaira"

GENPHARM AWARDED THE MEA MARKETS 2016 BEST PHARMACEUTICAL COMPANY.

United Kingdom, 2016- MEA Markets magazine announces the winners of the 2016 Business Awards. The Middle East & Africa is one of the world’s most diverse business centres, and has become the focus for many companies looking to move into a dynamic and vibrant region brimming with possibilities. The 2016 Business Awards are designed to recognise and reward the truly outstanding work done by the Middle East's and Africa’s most talented, dedicated and experienced businesses, departments and individuals. Tom Jones, Awards Co-ordinator, said: “With these awards we are turning the spotlight on the firms and individuals whose hard work and dedication have helped shape MEA region’s business landscape. It has been a true privilege showcasing the work of these dedicated professionals and their businesses, and I would like to wish them the very best of luck going forward.”

CAGS and Genpharm gear up for rare disease day in UAE

Rare Disease Day is an annual, awareness-raising event co-ordinated by EURORDIS at the international level and by National Alliances and Patient Organisations at the national level. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients’ lives.

ASPIRE Educational Series: Charcot-Marie-Tooth Disease (CMT)-Part 9

Charcot-Marie-Tooth (CMT) disease is one of the most common inherited neuromuscular disorders that affect the peripheral nerves. The disease is named for the three physicians who first identified it in 1886 - Jean-Martin Charcot and Pierre Marie in Paris, France, and Howard Henry Tooth in Cambridge, England. It's also known as hereditary motor and sensory neuropathy (HMSN) or peroneal muscular atrophy. Treatment of CMT is supportive. Ambulation aids, such as foot orthotics and braces (ankle-foot-orthotics, AFOs) are commonly needed to help with foot deformity and foot drop. Surgery to correct foot alignment or to lengthen or transfer tendons is often performed. Physical and occupational therapies are instrumental in providing long lasting quality of life. There is no cure for CMT nor any drug or vitamin known at this time.

GENPHARM Services - Your Gateway to the MENA Pharmaceutical Market

We are a specialty pharmaceutical marketing and consulting company, providing our strategic partners with fast and sustainable market access into the MENA (Middle East & North Africa) region, including business development, in-licensing and more. We operate through evidence-based medicine and the highest ethical standards. Our expertise is based on an in-depth knowledge of the pharmaceutical market and the local business culture. Furthermore, our vast experience and the trusted network of partners allow us to deliver market opportunities for specialty, rare disease, biotech and innovative healthcare organizations.

The MENA region has been experiencing fast economic and sustainable GDP growth. This positive outlook is driven by several factors providing pharmaceutical companies with untapped regional opportunities...
The healthcare sector in the MENA region has been experiencing sustainable double digit growth. Driven by unmet medical needs and increased medical public awareness, governments have been heavily investing in both infrastructure and access
We operate through a holistic market approach. We manage all relevant stakeholders for our partners, including Physicians, Patient groups, distributors and payers. Our expertise include KOL management, advocacy and CME programs..
Genpharm Services is managed by highly experienced Pharma executives. The operations are led by staff with a strong track record in senior leadership roles in multinational pharmaceutical organizations...